Miles Parkes

62.0k total citations · 3 hit papers
128 papers, 5.5k citations indexed

About

Miles Parkes is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Miles Parkes has authored 128 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Genetics, 46 papers in Epidemiology and 37 papers in Surgery. Recurrent topics in Miles Parkes's work include Inflammatory Bowel Disease (82 papers), Microscopic Colitis (34 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Miles Parkes is often cited by papers focused on Inflammatory Bowel Disease (82 papers), Microscopic Colitis (34 papers) and Helicobacter pylori-related gastroenterology studies (22 papers). Miles Parkes collaborates with scholars based in United Kingdom, United States and Australia. Miles Parkes's co-authors include Jack Satsangi, Dunecan Massey, Charlie W. Lees, Jeffrey C. Barrett, Derek P. Jewell, James Lee, David A. van Heel, Adrián Cortés, Matthew A. Brown and Ken I. Welsh and has published in prestigious journals such as Science, Cell and Journal of Clinical Investigation.

In The Last Decade

Miles Parkes

110 papers receiving 5.4k citations

Hit Papers

Disease-Specific Alterations i... 1996 2026 2006 2016 2015 1996 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease
    2015 906 citations Scott A. Handley, Megan T. Baldridge et al. profile →
  2. Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
    1996 561 citations Jack Satsangi, Miles Parkes et al. profile →
  3. New IBD genetics: common pathways with other diseases
    2011 472 citations Charlie W. Lees, Miles Parkes et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miles Parkes United Kingdom 36 2.8k 1.8k 1.7k 1.5k 1.1k 128 5.5k
Phillip Fleshner United States 38 2.5k 0.9× 1.6k 0.9× 953 0.6× 2.1k 1.4× 2.2k 2.0× 169 6.4k
Klaus Fellermann Germany 42 2.6k 0.9× 2.5k 1.4× 2.0k 1.1× 1.4k 0.9× 1.1k 1.0× 103 6.9k
Tim Raine United Kingdom 29 2.8k 1.0× 776 0.4× 1.4k 0.8× 2.0k 1.3× 1.0k 0.9× 97 4.9k
Yashwant R. Mahida United Kingdom 36 1.4k 0.5× 1.1k 0.6× 1.6k 0.9× 1.0k 0.7× 962 0.9× 91 4.6k
Ta‐Chiang Liu United States 38 2.7k 0.9× 2.4k 1.4× 988 0.6× 1.3k 0.8× 593 0.5× 98 5.8k
Heidi Britton Canada 11 2.1k 0.8× 2.0k 1.1× 1.9k 1.1× 1.3k 0.9× 971 0.9× 15 6.2k
Flavio Caprioli Italy 42 1.5k 0.5× 1.7k 1.0× 2.2k 1.3× 1.2k 0.8× 980 0.9× 149 5.7k
Kevin J. Maloy United Kingdom 43 2.1k 0.7× 3.0k 1.7× 6.5k 3.8× 1.2k 0.8× 1.5k 1.3× 63 10.1k
Ingrid Arijs Belgium 36 2.7k 1.0× 2.4k 1.3× 1.4k 0.8× 1.8k 1.2× 1.3k 1.2× 75 7.0k
Natalia Borruel Spain 25 1.4k 0.5× 2.1k 1.2× 447 0.3× 894 0.6× 637 0.6× 73 3.8k

Countries citing papers authored by Miles Parkes

Since Specialization
Citations

This map shows the geographic impact of Miles Parkes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miles Parkes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miles Parkes more than expected).

Fields of papers citing papers by Miles Parkes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miles Parkes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miles Parkes. The network helps show where Miles Parkes may publish in the future.

Co-authorship network of co-authors of Miles Parkes

This figure shows the co-authorship network connecting the top 25 collaborators of Miles Parkes. A scholar is included among the top collaborators of Miles Parkes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miles Parkes. Miles Parkes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molleston, Jerome M., Lawrence A. Schriefer, Lindsay Droit, et al.. (2025). Single cell viral tagging of Faecalibacterium prausnitzii reveals rare bacteriophages omitted by other techniques. Gut Microbes. 17(1). 2526719–2526719. 2 indexed citations
2.
3.
4.
Balarajah, Sharmili, Laura Martínez-Gili, James L. Alexander, et al.. (2024). OP07 Consistent IBD treatment approaches across South Asian and White ethnicities despite phenotypic variations: a study of 33,157 patients using the IBD BioResource. Journal of Crohn s and Colitis. 18(Supplement_1). i13–i13. 1 indexed citations
5.
Takahashi, Kazuya, Miles Parkes, Christine Norton, et al.. (2024). Factors associated with chronic abdominal pain in patients with inflammatory bowel disease in remission: A pilot cross‐sectional study. Neurogastroenterology & Motility. 36(10). e14881–e14881. 1 indexed citations
6.
Droit, Lindsay, Alejandro A. Vega, Kathie A. Mihindukulasuriya, et al.. (2023). Draft genomes of 12 Bifidobacterium isolates from human IBD fecal samples. Microbiology Resource Announcements. 13(1). e0013023–e0013023. 1 indexed citations
7.
Alexander, James L., Zhigang Liu, Hajir Ibraheim, et al.. (2023). P75 Vaccine-induced antibody responses against influenza are diminished in infliximab and tofacitinib-treated IBD patients and correlate with responses to COVID-19 vaccination. Poster presentations. A88.1–A88. 1 indexed citations
8.
Módos, Dezső, Padhmanand Sudhakar, Matthew Madgwick, et al.. (2022). A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis. Nature Communications. 13(1). 2299–2299. 16 indexed citations
9.
Goldberg, Rimma, Jennifer Clough, Luke B. Roberts, et al.. (2021). A Crohn’s Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling. Journal of Crohn s and Colitis. 15(12). 2054–2065. 5 indexed citations
10.
Rhodes, Jonathan M., Sreedhar Subramanian, Paul Flanagan, et al.. (2020). Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn’s Disease. Digestive Diseases and Sciences. 66(8). 2700–2711. 11 indexed citations
11.
Nelson, Andrew, Christopher J. Stewart, Nicholas A. Kennedy, et al.. (2020). The Impact ofNOD2Genetic Variants on the Gut Mycobiota in Crohn’s Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation. Journal of Crohn s and Colitis. 15(5). 800–812. 32 indexed citations
12.
13.
Biasci, Daniele, James Lee, Nurulamin M Noor, et al.. (2019). A blood-based prognostic biomarker in IBD. Gut. 68(8). 1386–1395. 127 indexed citations
14.
Parkes, Miles, Nurulamin M Noor, Francis Dowling, et al.. (2018). PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial. BMJ Open. 8(12). e026767–e026767. 41 indexed citations
15.
Bewshea, Claire, A F Muller, Ailsa Hart, et al.. (2013). OC-050 5-Aminosalicylate (5-Asa) Induced Nephrotoxicity in Inflammatory Bowel Disease. Gut. 62(Suppl 1). A22.1–A22. 4 indexed citations
16.
17.
Baburajan, Bijay, M Arenas, Natalie J. Prescott, et al.. (2007). The pharmacogenetics of folate and purine metabolic pathways in methotrexate therapy of inflammatory bowel disease.. Gut. 56. 1 indexed citations
18.
Vermeire, Séverine, Marc Peeters, Robert Vlietinck, et al.. (2000). Exclusion of Linkage of Crohnʼs Disease to Previously Reported Regions on Chromosomes 12, 7, and 3 in the Belgian Population Indicates Genetic Heterogeneity. Inflammatory Bowel Diseases. 6(3). 165–170. 23 indexed citations
19.
Vermeire, Séverine, Jack Satsangi, Marc Peeters, et al.. (1999). Fine mapping a susceptibility locus on the X chromosome in the Belgian population in inflammatory bowel disease (IBD). Gastroenterology. 116(4). 3 indexed citations
20.
Parkes, Miles, et al.. (1996). Liver. Gut. 39(Suppl 1). A18–A22. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip Fleshner Breakdown of academic impact, for papers by Klaus Fellermann Breakdown of academic impact, for papers by Tim Raine Breakdown of academic impact, for papers by Yashwant R. Mahida Breakdown of academic impact, for papers by Ta‐Chiang Liu Breakdown of academic impact, for papers by Heidi Britton Breakdown of academic impact, for papers by Flavio Caprioli Breakdown of academic impact, for papers by Kevin J. Maloy Breakdown of academic impact, for papers by Ingrid Arijs Breakdown of academic impact, for papers by Natalia Borruel
Rankless by CCL
2026